\(
\def\WIPO{World Intellectual Property Organisation}
\)
Competition Law and Patents : A Follow-on Innovation Perspective in the Biopharmaceutical Industry.
2008
G 25 HAR.C
Available at WIPO Library
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
Details
Title
Competition Law and Patents : A Follow-on Innovation Perspective in the Biopharmaceutical Industry.
Author
Item Type
Book
Description
272 pages.
ISBN
9781848440111 eBook
9781847205995 Print
9781847205995 Print
Alternate Call Number
G 25 HAR.C
Note
Description based upon print version of record.
Formatted Contents Note
Preface
Acknowledgements
Cases
Part I The problem - access as a necessary element of follow-on innovation?
1. Biopharmaceutical R&D: the increased importance of cumulative innovation and related concerns
Part II The patent balance and working solutions in the patent system
2. The patent system as a system of balancing
3. The patent system and some potential safety nets
4. The right to health as an interpretive principle of patent law
PART III Antitrust as a complement to the patent system
5. Unilateral conduct, intellectual property rights and competition law: a systems' interaction
6. The duty to deal under Art. 82 EC
PART IV A more innovation sensitive approach to the interface of competition law and patents?
7. The duty to deal as applied to address technology access problems in the biopharmaceutical industry
Bibliography
Index.
Acknowledgements
Cases
Part I The problem - access as a necessary element of follow-on innovation?
1. Biopharmaceutical R&D: the increased importance of cumulative innovation and related concerns
Part II The patent balance and working solutions in the patent system
2. The patent system as a system of balancing
3. The patent system and some potential safety nets
4. The right to health as an interpretive principle of patent law
PART III Antitrust as a complement to the patent system
5. Unilateral conduct, intellectual property rights and competition law: a systems' interaction
6. The duty to deal under Art. 82 EC
PART IV A more innovation sensitive approach to the interface of competition law and patents?
7. The duty to deal as applied to address technology access problems in the biopharmaceutical industry
Bibliography
Index.
Linked Resources
Published
Northampton : Edward Elgar Publishing, 2008.
Language
English
Record Appears in